Učitavanje...
Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs
BACKGROUND: Monthly topical and sustained-release injectable formulations of moxidectin are currently marketed; however, an oral formulation, while approved at a dose of 3 μg/kg, is not currently marketed in the United States. Although resistance of heartworms to all macrocyclic lactone (ML) heartwo...
Spremljeno u:
| Izdano u: | Parasit Vectors |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5688394/ https://ncbi.nlm.nih.gov/pubmed/29143634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-017-2429-5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|